Cargando…

Management of Elderly Asthma: Key Questions and Tentative Answers

The aging lung undergoes structural changes, immunosenescence, and inflammation, rendering the elderly more susceptible to developing obstructive airway disease. Thus, asthma in those of chronological age ≥ 65 years is not rare. Elderly asthma (EA) imposes considerable burdens in terms of mortality...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Heung-Woo, Cho, Sang Heon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880298/
https://www.ncbi.nlm.nih.gov/pubmed/36693354
http://dx.doi.org/10.4168/aair.2023.15.1.8
_version_ 1784878877047259136
author Park, Heung-Woo
Cho, Sang Heon
author_facet Park, Heung-Woo
Cho, Sang Heon
author_sort Park, Heung-Woo
collection PubMed
description The aging lung undergoes structural changes, immunosenescence, and inflammation, rendering the elderly more susceptible to developing obstructive airway disease. Thus, asthma in those of chronological age ≥ 65 years is not rare. Elderly asthma (EA) imposes considerable burdens in terms of mortality and morbidity, and expenditure. However, clinicians lack knowledge of EA and thus often prescribe inappropriate management. In this review, we ask 3 key questions frequently encountered during EA diagnosis and treatment: 1) Is EA different?; 2) How can we appropriately diagnose EA?; 3) Are there management strategies specific to EA? Based on recent studies, we provide tentative answers as follows: 1) late-onset EA differs in clinical features and pathogenetic mechanisms from non-EA, and thus further phenotypic and endotypic characterization of EA is needed; 2) both over- and under-diagnosis of asthma in the elderly can be reduced if the objective diagnostic tests are appropriately performed; 3) cautious prescription of ICS to selected EA patients should be encouraged, and a multifaceted approach which involves increasing medical awareness and inhaler use proficiency and adherence, seeking the assistance of caregivers, and correcting micronutrient deficiencies is required to reduce acute exacerbations in EA patients.
format Online
Article
Text
id pubmed-9880298
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
record_format MEDLINE/PubMed
spelling pubmed-98802982023-02-07 Management of Elderly Asthma: Key Questions and Tentative Answers Park, Heung-Woo Cho, Sang Heon Allergy Asthma Immunol Res Review The aging lung undergoes structural changes, immunosenescence, and inflammation, rendering the elderly more susceptible to developing obstructive airway disease. Thus, asthma in those of chronological age ≥ 65 years is not rare. Elderly asthma (EA) imposes considerable burdens in terms of mortality and morbidity, and expenditure. However, clinicians lack knowledge of EA and thus often prescribe inappropriate management. In this review, we ask 3 key questions frequently encountered during EA diagnosis and treatment: 1) Is EA different?; 2) How can we appropriately diagnose EA?; 3) Are there management strategies specific to EA? Based on recent studies, we provide tentative answers as follows: 1) late-onset EA differs in clinical features and pathogenetic mechanisms from non-EA, and thus further phenotypic and endotypic characterization of EA is needed; 2) both over- and under-diagnosis of asthma in the elderly can be reduced if the objective diagnostic tests are appropriately performed; 3) cautious prescription of ICS to selected EA patients should be encouraged, and a multifaceted approach which involves increasing medical awareness and inhaler use proficiency and adherence, seeking the assistance of caregivers, and correcting micronutrient deficiencies is required to reduce acute exacerbations in EA patients. The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2023-01-09 /pmc/articles/PMC9880298/ /pubmed/36693354 http://dx.doi.org/10.4168/aair.2023.15.1.8 Text en Copyright © 2023 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Park, Heung-Woo
Cho, Sang Heon
Management of Elderly Asthma: Key Questions and Tentative Answers
title Management of Elderly Asthma: Key Questions and Tentative Answers
title_full Management of Elderly Asthma: Key Questions and Tentative Answers
title_fullStr Management of Elderly Asthma: Key Questions and Tentative Answers
title_full_unstemmed Management of Elderly Asthma: Key Questions and Tentative Answers
title_short Management of Elderly Asthma: Key Questions and Tentative Answers
title_sort management of elderly asthma: key questions and tentative answers
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880298/
https://www.ncbi.nlm.nih.gov/pubmed/36693354
http://dx.doi.org/10.4168/aair.2023.15.1.8
work_keys_str_mv AT parkheungwoo managementofelderlyasthmakeyquestionsandtentativeanswers
AT chosangheon managementofelderlyasthmakeyquestionsandtentativeanswers